Financial statements Acelis Pharma

Balance sheet of Acelis Pharma

Company age:
Age:
13 y. 29 d.
Share capital:
Share capital:
7 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of ACELIS PHARMA

Year
2018
2019
2020
2021
Total assets 152 894,61 151 336,21 150 742,21 150 423,69
A. Fixed assets 3 130,00 2 683,00 2 236,00 1 789,00
B. Current assets 149 764,61 148 653,21 148 506,21 148 634,69
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 152 894,61 151 336,21 150 742,21 150 423,69
A. Equity 129 213,75 127 480,40 126 886,40 125 880,80
B. Liabilities and provisions for liabilities 23 680,86 23 855,81 23 855,81 24 542,89
I. Long-term liabilities 0,00 0,00 0,00 0,00
II. Short-term liabilities 23 680,86 23 855,81 23 855,81 24 542,89
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.